• Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Recommendation of "Buy" from Brokerages

    Source: Buzz FX / 23 Dec 2024 02:02:12   America/Chicago


    Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Recommendation of "Buy" from Brokerages Written by MarketBeat December 23, 2024 Share Link copied to clipboard. Day One Biopharmaceuticals, Inc.
    Read more...
Share on,